In in vitro experiments, non-small cell lung cancer cell lines that became resistant to cisplatin treatment were reported to have elevated visfatin levels, whereas visfatin KO restored sensitivity to cisplatin [149]. Here, NAMPT is linked to non-small cell lung carcinoma.